A detailed history of Bank Of Nova Scotia transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 861 shares of BIO stock, worth $286,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
861
Previous 2,100 59.0%
Holding current value
$286,635
Previous $573,000 49.74%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$263.97 - $344.64 $327,058 - $427,008
-1,239 Reduced 59.0%
861 $288,000
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $150,762 - $190,787
-562 Reduced 21.11%
2,100 $573,000
Q1 2024

May 14, 2024

BUY
$304.11 - $351.99 $8,515 - $9,855
28 Added 1.06%
2,662 $920,000
Q4 2023

Feb 12, 2024

BUY
$269.37 - $365.04 $176,437 - $239,101
655 Added 33.1%
2,634 $850,000
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $77,405 - $93,401
221 Added 12.57%
1,979 $709,000
Q2 2023

Aug 03, 2023

BUY
$359.49 - $486.4 $89,872 - $121,600
250 Added 16.58%
1,758 $666,000
Q1 2023

May 11, 2023

SELL
$418.69 - $503.0 $121,420 - $145,870
-290 Reduced 16.13%
1,508 $722,000
Q4 2022

Feb 09, 2023

SELL
$351.71 - $456.01 $2,110 - $2,736
-6 Reduced 0.33%
1,798 $756,000
Q3 2022

Nov 10, 2022

SELL
$412.59 - $563.26 $825 - $1,126
-2 Reduced 0.11%
1,804 $753,000
Q2 2022

Aug 05, 2022

SELL
$463.67 - $597.16 $9.37 Million - $12.1 Million
-20,198 Reduced 91.79%
1,806 $893,000
Q1 2022

May 09, 2022

SELL
$524.57 - $735.42 $1.8 Million - $2.53 Million
-3,436 Reduced 13.51%
22,004 $12.4 Million
Q4 2021

Feb 11, 2022

BUY
$708.84 - $794.68 $10.5 Million - $11.7 Million
14,785 Added 138.76%
25,440 $19.2 Million
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $4.81 Million - $6.04 Million
7,312 Added 218.73%
10,655 $7.95 Million
Q2 2021

Aug 12, 2021

BUY
$576.64 - $649.04 $1.93 Million - $2.17 Million
3,343 New
3,343 $2.15 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.